ID
28103
Description
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology
Keywords
Versions (2)
- 12/18/17 12/18/17 -
- 1/22/18 1/22/18 -
Copyright Holder
Prof. Dr. Dr. h.c. Thomas Luger
Uploaded on
December 18, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Visit 4 Psoriasis NCT02695940
Visit 4 Psoriasis NCT02695940
- StudyEvent: ODM
Description
I. Medical History und körperliche Untersuchung
Description
Physical Examination
Data type
boolean
Description
Concomitant Medikation
Data type
boolean
Description
Physician Global Assessment
Data type
boolean
Description
Total Sign Score
Data type
boolean
Description
treated body regions
Data type
boolean
Description
blood values
Data type
boolean
Description
adverse events
Data type
text
Description
change concomitant medication
Data type
text
Description
information medical condition
Data type
boolean
Description
medical condition information staff member
Data type
text
Description
II. Medikation
Description
Drug Account entry
Data type
boolean
Description
instruction dosage medication
Data type
boolean
Description
Patient wurde darauf hingewiesen, am Tag der nächsten Visite keine Pflegeprodukte zu verwenden
Data type
boolean
Description
Unterschrift
Similar models
Visit 4 Psoriasis NCT02695940
- StudyEvent: ODM